Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Pharm Biomed Anal. 2012 May 23;70:320–329. doi: 10.1016/j.jpba.2012.05.008

Table 3.

Calibration curves of bupropion and its three metabolites in umbilical cord plasma and placental tissue (n=3).

Bio-matrix Analytea Regression equationb, c r2 F-testd
Linear rangec LODc
F p-Value
Umbilical cord plasma BUP y=0.007+0.074x 0.995 0.79 0.614 0.250-250 0.050
OH-BUP y=0.010+0.089x 0.996 1.02 0.434 0.715-715 0.072
EB y=0.004+0.181x 0.996 1.01 0.440 0.245-245 0.049
TB y=0.022+0.183x 0.995 1.00 0.447 0.365-365 0.073
Placental tissue BUP y=0.011+0.110x 0.992 1.31 0.301 0.312-250 0.125
OH-BUP y=0.023+0.174x 0.991 1.33 0.294 0.895-716 0.179
EB y=0.005+0.199x 0.991 1.09 0.411 0.305-244 0.122
TB y=0.015+0.132x 0.989 1.41 0.262 0.918-734 0.184
a

BUP=buproipion, OH-BUP=hydroxybupropion, EB=erythrohydrobupropion, TB=threohydrobupropion.

b

In the regression equation y=b+ax, x refers to the concentration of the analyte in bio-matrix; y refers to the peak area ratio of the analyte vs. IS.

c

The unit of analyte in umbilical cord plasma is ng/mL; the unit of analyte in placental tissue is ng/g.

d

F-test for lack-of-fit.